BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q1 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,198 | -10.8% | 297,120 | -5.3% | 0.07% | -7.9% |
Q2 2023 | $33,839 | +13.8% | 313,671 | +27.3% | 0.08% | +1.3% |
Q1 2023 | $29,741 | -23.5% | 246,356 | -2.5% | 0.08% | -27.2% |
Q4 2022 | $38,860 | -99.9% | 252,780 | -11.3% | 0.10% | -8.0% |
Q3 2022 | $37,997,000 | -18.2% | 284,939 | -11.3% | 0.11% | -17.0% |
Q2 2022 | $46,435,000 | -14.1% | 321,120 | +3.9% | 0.14% | +2.3% |
Q1 2022 | $54,069,000 | +4.6% | 309,035 | +45.1% | 0.13% | +4.8% |
Q4 2021 | $51,708,000 | +3.3% | 212,996 | +18.7% | 0.13% | -10.0% |
Q3 2021 | $50,060,000 | -5.2% | 179,496 | -23.2% | 0.14% | -9.1% |
Q2 2021 | $52,782,000 | +1.2% | 233,677 | -51.6% | 0.15% | -11.0% |
Q1 2021 | $52,148,000 | +334.9% | 482,377 | +259.3% | 0.17% | +284.4% |
Q4 2020 | $11,990,000 | -27.7% | 134,253 | -45.2% | 0.04% | -39.2% |
Q3 2020 | $16,577,000 | +141.4% | 245,000 | +136.0% | 0.07% | +72.1% |
Q2 2020 | $6,868,000 | +89.6% | 103,800 | +73.0% | 0.04% | +53.6% |
Q1 2020 | $3,622,000 | -61.7% | 60,000 | -78.3% | 0.03% | -51.7% |
Q4 2019 | $9,462,000 | – | 277,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
Systrade AG | 50,000 | $5,432,000 | 4.70% |
Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
AtonRa Partners | 4,707 | $511,368 | 1.07% |
Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |